Abstract
The assessment of nodal metastases in gynecological surgical specimen is an important staging parameter, directing further therapeutic procedures. Since the number of lymph nodes (LNs) removed is seen as an indicator of surgical and pathological quality, the demand for higher lymph node (LN) counts is raising. The goal of this prospective study was the comparison between lymph node counts of macroscopically detectable LNs and the LN yield by complete embedding and proceeding of all submitted LN-containing tissue in the pathology laboratory. One hundred six cases of cervical, uterine, or ovarian cancer, treated in three different hospitals within 3 years, were analyzed. All tissue submitted to the pathology from the surgically performed LN dissections was completely dissected and embedded in the institute of pathology. Subsequently, the amount of LN of all macroscopically detectable nodes was compared to the final histologically reached numbers of LN. Furthermore the histologically visible area of the LNs and their metastases was analyzed to assess the relation of LN numbers to the whole examined LN area. Complete embedding raises the average number of LN counted by 3 to 7 but did only minimally increase the LN area for microscopical examination by about 5% due to the small area of the additional LNs in the remaining fat tissue. The staging was in no case altered by complete embedding, even when additional nodal metastases were detected in the remaining fat tissue, since this was only seen in cases which had already metastatic nodes. Complete embedding of LN-containing tissue did not provide relevant additional staging information and seems therefore unnecessarily laborious, careful pathological work-up assumed.
Similar content being viewed by others
Abbreviations
- H&E :
-
Hematoxylin and eosin stain
- LN:
-
Lymph node
- LNs :
-
Lymph nodes
- LNM :
-
Lymph node metastasis
- LNMs :
-
Lymph node metastases
- TNM :
-
Tumor node metastasis
- UICC :
-
Union internationale contre le cancer
References
Fujimoto T, Fukuda J, Tanaka T (2009) Role of complete para-aortic lymphadenectomy in endometrial cancer. Curr Opin Obstet Gynecol 21:10–14. https://doi.org/10.1097/GCO.0b013e32831ac3ac
Possover M, Krause N, Plaul K, Kühne-Heid R, Schneider A (1998) Laparoscopic para-aortic and pelvic lymphadenectomy: experience with 150 patients and review of the literature. Gynecol Oncol 71:19–28
Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J (2010) Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Int J Gynecol Cancer 20:1000–1005. https://doi.org/10.1111/IGC.0b013e3181d80aff
Lin JF, Muñiz K, Sukumvanich P, Gehrig P, Beriwal S, Kelley JL, Edwards RP, Olawaiye AB (2016) Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study. BJOG 123:1846–1852. https://doi.org/10.1111/1471-0528.13726
Wong AT, Rineer J, Lee YC, Schwartz D, Safdieh J, Weiner J, Choi K, Schreiber D (2016) Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma. Gynecol Oncol 142:514–519. https://doi.org/10.1016/j.ygyno.2016.07.091
Forde GK, Carlson JW, Downey GO, Doss BJ, Shoemaker A, Harrison CR (2011) A quality process study of lymph node evaluation in endometrial cancer. Int J Gynecol Pathol 30:335–339. https://doi.org/10.1097/PGP.0b013e31820dc39d
Stehman FB, Ali S, DiSaia PJ (2009) Node count and groin recurrence in early vulvar cancer: a gynecologic oncology group study. Gynecol Oncol 113:52–56. https://doi.org/10.1016/j.ygyno.2008.12.028
Santoso JT, Azadi A, Wan J, Handorf C, Coleman RL, Tillmanns TD (2009) Lymph node counts in uterine cancer: a randomized double blind trial. Gynecol Oncol 113:159–162
Bell MC, Torgerson J, Seshadri-Kreaden U, Suttle AW, Hunt S (2008) Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques. Gynecol Oncol 111:407–411. https://doi.org/10.1016/j.ygyno.2008.08.022
Hareyama H, Ito K, Watanabe S, Hakoyama M, Uchida A, Oku K, Watanabe Y, Hayakashi Y, Hirayama E, Okuyama K (2012) Factors influencing the number of pelvic and para-aortic lymph nodes removed in surgical treatment of endometrial and ovarian cancer. Int J Gynecol Cancer 22:1577–1584. https://doi.org/10.1097/IGC.0b013e31826fd644
Kokka F, Bryant A, Brockbank E, Powell M, Oram D (2015) Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database Syst Rev https://doi.org/10.1002/14651858.CD010260
Fleming ND, Soliman PT, Westin SN, dos Reis R, Munsell M, Klopp AH, Frumovitz M, Nick AM, Schmeler K, Ramirez PT (2015) Impact of lymph node ratio and adjuvant therapy in node-positive endometrioid endometrial cancer. Int J Gynecol Cancer 25:1437–1444. https://doi.org/10.1097/IGC.0000000000000510
Frost JA, Webster KE, Bryant A, Morrison J (2017) Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007585.pub4
Pereira A, Irishina N, Pérez-Medina T, Magrina JF, Magtibay PM, Kovaleva A, Rodriguez-Tapia A, Iglesias E (2013) Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation. Eur J Surg Oncol 39:290–296. https://doi.org/10.1016/j.ejso.2012.12.006
Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:11–18. https://doi.org/10.1016/j.ygyno.2008.01.023
Zaal A, Zweemer RP, Zikán M, Dusek L, Querleu D, Lécuru F, Bats AS, Jach R, Sevcik L, Graf P, Klát J, Dyduch G, von Mensdorff-Pouilly S, Kenter GG, Verheijen RH, Cibula D (2014) Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: a retrospective multicenter cohort study. Int J Gynecol Cancer 24:303–311. https://doi.org/10.1097/IGC.0000000000000043
McMeekin DS, Tillmanns T (2003) Endometrial cancer: treatment of nodal metastases. Curr Treat Options in Oncol 4:121–130
Vidal F, Rafii A (2013) Lymph node assessment in endometrial cancer: towards personalized medicine. Obstet Gynecol Int 2013(892465):1–8. https://doi.org/10.1155/2013/892465
Euscher ED, Bassett R, Malpica A (2011) Lymph node counts in endometrial cancer: expectations versus reality. Am J Surg Pathol 35:913–918. https://doi.org/10.1097/PAS.0b013e31821899be
Lanowska M, Vasiljeva J, Chiantera V, Marnitz S, Schneider A, Rudolph B, Köhler C (2010) Implication of the examining pathologist to meet the oncologic standard of lymph node count after laparoscopic lymphadenectomy. Oncology 79:161–167. https://doi.org/10.1159/000322158
Chan JK, Urban R, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Walker JL, Kapp DS, Osann K (2007) Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer 109:2454–2460
Cormier B, Sauthier P, Lussier C, Zang G, Mayrand MH (2012) Determinants of lymph node count in endometrial cancer surgical staging. Int J Gynecol Cancer 22:1361–1366
Johnson L, Bunn WD, Nguyen L, Rice J, Raj M, Cunningham MJ (2017) Clinical comparison of robotic, laparoscopic, and open hysterectomy procedures for endometrial cancer patients. J Robot Surg 11:291–297. https://doi.org/10.1007/s11701-016-0651-3
Eklind S, Lindfors A, Sjöli P, Dahm-Kähler P (2015) A prospective, comparative study on robotic versus open-surgery hysterectomy and pelvic lymphadenectomy for endometrial carcinoma. Int J Gynecol Cancer 25:250–256. https://doi.org/10.1097/IGC.0000000000000357
Salman MC, Usubutun A, Ozlu T, Boynukalin K, Yuce K (2010) Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers. J Gynecol Oncol 21:24–28
Scribner DR Jr, Walker JL, Johnson GA, McMeekin SD, Gold MA, Mannel RS (2001) Laparoscopic pelvic and paraaortic lymph node dissection: analysis of the first 100 cases. Gynecol Oncol 82:498–503
Author information
Authors and Affiliations
Contributions
Authorship of all authors is based on the following:
• Substantial contributions to the conception or design of the work or the acquisition, analysis, or interpretation of data for the work; and
• Drafting the work or revising it critically for important intellectual content; and
• Final approval of the version to be published; and
• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Ethical standards
The present study follows the guidelines of the revised UN declaration of Helsinki in 1975 and its latest amendment in 2008 (6th revision) and was approved by the Local Research Ethical Committee (No. 244/14).
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Andruszkow, J., Meinhold-Heerlein, I., Winkler, B. et al. The impact of complete embedding of remaining tissue in gynecological lymph node dissection specimen in surgical pathology on lymph node yield: is it clinically relevant?. Virchows Arch 473, 183–188 (2018). https://doi.org/10.1007/s00428-018-2363-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-018-2363-8